HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Lin Selected Research

Solitary Pulmonary Nodule

3/2019The value of 18F-FDG PET/CT in the diagnosis of different size of solitary pulmonary nodules.
1/2018Spectral CT Analysis of Solitary Pulmonary Nodules for Differentiating Malignancy from Benignancy: The Value of Iodine Concentration Spatial Distribution Difference.
1/2018The Value of 18F-FDG PET/CT Mathematical Prediction Model in Diagnosis of Solitary Pulmonary Nodules.
7/2015Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Lin Research Topics

Disease

130Neoplasms (Cancer)
04/2022 - 01/2004
21Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 10/2003
21Neoplasm Metastasis (Metastasis)
03/2022 - 09/2005
21Urinary Bladder Neoplasms (Bladder Cancer)
12/2021 - 09/2004
15Hepatocellular Carcinoma (Hepatoma)
02/2022 - 01/2012
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 11/2008
14Glioma (Gliomas)
01/2022 - 01/2018
14Breast Neoplasms (Breast Cancer)
01/2022 - 12/2009
14Inflammation (Inflammations)
01/2022 - 01/2007
14Carcinogenesis
01/2022 - 11/2006
13Infections
01/2022 - 03/2002
13Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 07/2005
12Lung Neoplasms (Lung Cancer)
01/2020 - 06/2007
11Stomach Neoplasms (Stomach Cancer)
07/2022 - 04/2004
10Ischemia
12/2021 - 06/2004
9Carcinoma (Carcinomatosis)
01/2022 - 08/2003
8Hypoxia (Hypoxemia)
12/2021 - 11/2011
7Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 12/2010
7Atrial Fibrillation
01/2022 - 05/2007
7Colonic Neoplasms (Colon Cancer)
12/2021 - 09/2005
7Atherosclerotic Plaque (Atheroma)
04/2021 - 03/2013
7Adenocarcinoma
01/2020 - 09/2005
7Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
03/2019 - 10/2003
6Fibrosis (Cirrhosis)
04/2022 - 05/2016
6Nasopharyngeal Carcinoma
12/2021 - 01/2017
6Reperfusion Injury
12/2021 - 06/2004
6MELAS Syndrome (Syndrome, MELAS)
07/2021 - 02/2014
6Diabetic Cardiomyopathies
02/2021 - 01/2017
6Atherosclerosis
01/2021 - 05/2012
6Coronary Disease (Coronary Heart Disease)
01/2021 - 04/2006
6Myocardial Infarction
01/2020 - 03/2011
6Homozygous Familial Hypercholesterolemia
07/2019 - 10/2003
6Muscular Diseases (Myopathy)
01/2019 - 03/2011
6Renal Cell Carcinoma (Grawitz Tumor)
01/2014 - 08/2008
5COVID-19
08/2022 - 01/2020
5Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2022 - 12/2017
5Neuromyelitis Optica (Devic's Disease)
01/2022 - 06/2017
5Stroke (Strokes)
01/2022 - 02/2014
5Hypertension (High Blood Pressure)
01/2021 - 03/2009
5Lymphatic Metastasis
01/2021 - 05/2014
5Squamous Cell Carcinoma of Head and Neck
03/2020 - 10/2010
5Type 2 Diabetes Mellitus (MODY)
01/2020 - 06/2007
4Prostatic Neoplasms (Prostate Cancer)
01/2022 - 10/2002
4Non-alcoholic Fatty Liver Disease
04/2021 - 10/2017
4Coronary Artery Disease (Coronary Atherosclerosis)
04/2021 - 02/2013
4Pathologic Constriction (Stenosis)
04/2021 - 05/2008
4Insulin Resistance
01/2021 - 03/2009
4Thymoma (Thymic Carcinoma)
01/2021 - 02/2009
4Hemorrhage
11/2020 - 06/2018
4Heart Failure
03/2020 - 10/2015
4Brain Neoplasms (Brain Tumor)
01/2020 - 07/2017
4Solitary Pulmonary Nodule
03/2019 - 07/2015
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 07/2011
4Lymphoma (Lymphomas)
12/2018 - 02/2003

Drug/Important Bio-Agent (IBA)

41Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2003
34Biomarkers (Surrogate Marker)IBA
12/2022 - 12/2009
25MicroRNAs (MicroRNA)IBA
01/2022 - 11/2008
22Biological ProductsIBA
12/2022 - 12/2008
22Messenger RNA (mRNA)IBA
01/2022 - 01/2004
15CytokinesIBA
07/2022 - 01/2010
13DNA (Deoxyribonucleic Acid)IBA
06/2018 - 10/2003
11LDL Lipoproteins (beta Lipoproteins)IBA
01/2020 - 07/2005
10Pharmaceutical PreparationsIBA
04/2022 - 11/2008
9Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2021 - 07/2015
9CateninsIBA
01/2021 - 12/2015
8Phosphotransferases (Kinase)IBA
09/2022 - 02/2003
8AntigensIBA
01/2022 - 03/2002
8LipidsIBA
09/2021 - 09/2010
8Glucose (Dextrose)FDA LinkGeneric
04/2021 - 06/2004
7Cisplatin (Platino)FDA LinkGeneric
10/2022 - 11/2008
6Indicators and Reagents (Reagents)IBA
06/2022 - 10/2010
6EnzymesIBA
06/2021 - 01/2008
6oxidized low density lipoproteinIBA
01/2021 - 10/2003
5AntibodiesIBA
04/2022 - 11/2018
5Rituximab (Mabthera)FDA Link
03/2022 - 10/2012
5RNA (Ribonucleic Acid)IBA
01/2022 - 01/2019
5Peptides (Polypeptides)IBA
01/2019 - 12/2003
5Small Interfering RNA (siRNA)IBA
01/2019 - 10/2014
5PlatinumIBA
06/2015 - 11/2008
5DecitabineFDA Link
04/2013 - 08/2008
5LDL Receptors (LDL Receptor)IBA
05/2010 - 10/2003
4HDL CholesterolIBA
06/2022 - 12/2016
4Glutathione (Reduced Glutathione)IBA
02/2022 - 01/2012
4Circular RNAIBA
12/2021 - 10/2019
4salicylhydroxamic acid (SHAM)IBA
12/2021 - 01/2009
4Estrogens (Estrogen)FDA Link
10/2021 - 03/2014
4Long Noncoding RNAIBA
01/2021 - 12/2018
4ErbB Receptors (EGF Receptor)IBA
01/2020 - 01/2014
4LDL CholesterolIBA
07/2019 - 09/2010
4CholesterolIBA
10/2018 - 09/2010
4ORALIT (ORS)IBA
01/2017 - 03/2007
4Matrix Metalloproteinases (MMPs)IBA
06/2015 - 05/2007
4Telomerase (Telomerase Reverse Transcriptase)IBA
02/2015 - 11/2009

Therapy/Procedure

33Therapeutics
02/2022 - 12/2009
22Drug Therapy (Chemotherapy)
02/2022 - 11/2008
17Radiotherapy
12/2021 - 07/2011
7Stents
11/2020 - 04/2006
6Immunotherapy
01/2022 - 01/2010
6Aftercare (After-Treatment)
01/2021 - 02/2009
4Chemoradiotherapy
09/2019 - 02/2009